drugset

drugset / Trial / NCT07560735

Clinical Evaluation of Lifitegrast Ophthalmic Solution 5.0% in Dry Eye Disease Using In Vivo Confocal Microscopy

NCT07560735 ↗

Phase 4 Not yet recruiting 30 enrolled Toyos Clinic

NaSingle-groupOpen-labelTreatment

Summary

This is a single center, open label trial to evaluate Lifitegrast Ophthalmic Solution 5.0% in Dry Eye Disease using In Vivo Confocal Microscopy (IVCM

Timeline

Start: 2026-04
Primary completion: 2026-09
Completion: 2027-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lifitegrast	Unknown	5 %	—

Indications